Table 2.
Variables | No. of patients |
Median survival (months) |
p value |
---|---|---|---|
Age (years) | NS | ||
>60 | 7 | 38 | |
≤60 | 30 | 63 | |
Gender | NS | ||
Male | 32 | 50 | |
Female | 5 | 65 | |
Serum AFP (ng/mL) | NS | ||
>100 | 13 | 50 | |
≤100 | 24 | 59 | |
Serum total bilirubin (umol/L) | NS | ||
>20 | 8 | 35 | |
≤20 | 29 | 63 | |
Serum ALT (IU/L) | NS | ||
>40 | 12 | 37 | |
≤40 | 25 | 59 | |
Serum AST (IU/L) | NS | ||
>40 | 7 | 48 | |
≤40 | 30 | 59 | |
Background liver tissue | NS | ||
Non-cirrhotic | 17 | 64 | |
Cirrhotic | 20 | 44 | |
Tumors capsule formation | NS | ||
Absent | 11 | 48 | |
Present | 26 | 64 | |
Tumors size (cm) | NS | ||
>3 | 15 | 50 | |
≤3 | 22 | 59 | |
Number of tumors | 0.040 | ||
Solitary | 28 | 64 | |
Multiple | 9 | 37 | |
Vascular invasion | 0.004 | ||
Absent | 18 | 68 | |
Present | 19 | 38 | |
Edmonson-Steiner grade | NS | ||
G1-G2 | 4 | 50 | |
G3-G4 | 33 | 59 | |
Recurrence-free interval (year) | <0.001 | ||
>1 | 29 | 64 | |
≤1 | 8 | 29 |
AFP: alpha-fetoprotein. ALT: alanine aminotransferase. AST: aspartate aminotransferase.